Form 4 Filing for RenovoRx, Inc. - VOLL MARK Transaction

This filing details a transaction by Mark Voll, Chief Financial Officer of RenovoRx, Inc., on April 3, 2026. Mr. Voll acquired 80,000 shares of Common Stock. The transaction code indicates an acquisition with a price per share of $0.00, as noted in footnote F1. This footnote also specifies that the reported transaction involved the receipt of restricted stock units (RSUs) for services rendered and to be rendered as Chief Financial Officer. Following this transaction, Mr. Voll directly owns 117,380 shares. Additionally, the filing indicates indirect ownership of 97,200 shares through the Voll Family Trust.